The Biomedical Publications Industry Must Change to Better Serve the Needs of Science and Scientists

Main Article Content

Michael M. Lederman
Neil S. Greenspan

Abstract

The biomedical publications industry is vital to progress in science and health care. We observe that this industry has become unnecessarily complex and expensive for researchers and readers, impeding the sharing of research findings. In this perspective, we offer selected critiques of this industry and suggest how it might be improved.

Downloads

Download data is not yet available.

Article Details

Section
Commentaries

References

1. Nicholson C. Elsevier parent reports 10% hike in profits for 2023. Research Professional News. Published February 13, 2025. Accessed March 2025. https://www.researchprofessionalnews.com/rr-news-world-2025-2-elsevier-parent-company-reports-10-rise-in-profit-to-3-2bn/

2. Clotworthy A, Davies M, Cadman TJ, Bengtsson J, Andersen TO, Kadawathagedara M, Vinther JL, Nguyen TL, Varga TV. Saving time and money in biomedical publishing: the case for free-format submissions with minimal requirements. BMC Med. 2023;21(1):172. doi: 10.1186/s12916-023-02882-y. PubMed PMID: 37161428; PMCID: PMC10170849.

3. Abizadeh A. Academic journals are a lucrative scam – and we’re determined to change that. Manchester Guardian. Published July 16, 2024. Accessed February 2025. https://www.theguardian.com/commentisfree/article/2024/jul/16/academic-journal-publishers-universities-price-subscriptions

Most read articles by the same author(s)